Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Invivyd Inc., 3 years.
Invivyd Inc.
Director
Exelixis Inc.
Director
Xilio Therapeutics Inc.
Director
Legend Biotech Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Exelixis Inc. | Grant or award | +8,367 | — | — |
| May 29, 2025 | Exelixis Inc. | Grant or award | +9,812 | — | — |
| May 21, 2025 | Exelixis Inc. | Open-market sale | −4,544 | $44.29 | $201,254 |
| May 31, 2024 | Exelixis Inc. | Grant or award | +18,838 | — | — |
| May 31, 2023 | Exelixis Inc. | Grant or award | +18,176 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.